Abbreviations and acronyms


1,25(OH)2D	1,25-Dihydroxyvitamin D	KDOQI	Kidney Disease Outcomes Quality Initiative
25(OH)D	25-Hydroxyvitamin D	KDQOL	Kidney Disease Quality of Life Instrument
ACC/AHA	American College of Cardiology/American Heart Association	LDL-C	Low-density lipoprotein cholesterol
AE	Adverse event	MGP	Matrix Gla protein
ALP	Alkaline phosphatases	MDRD	Modification of Diet in Renal Disease
b-ALP	Bone-specific alkaline phosphatase	MLT	Mineralization lag time
BMD	Bone mineral density	MSCT	Multislice computed tomography
BRIC	Bone Relationship with Inflammation and Coronary Calcification	N	Number of subjects
BV	Bone volume	NAPRTCS	North American Renal Trials and Cooperative Studies
CAC	Coronary artery calcification	NHANES	National Health and Nutrition Examination Survey
CaR	Calcium-sensing receptor	NKF	National Kidney Foundation
Ca x P	Calcium–phosphorus product	NTX	Aminoterminal cross-linking telopeptide of bone collagen
CI	Confidence interval	OC	Osteocalcin
CKD	Chronic kidney disease	OPG	Osteoprotegerin
CKD–MBD	Chronic kidney disease–mineral and bone disorder	OR	Odds ratio
CrCl	Creatinine clearance	PD	Peritoneal dialysis
CT	Computed tomography	PICP	Procollagen type I C propeptide
CTX	Carboxyterminal cross-linking telopeptide of bone collagen	PINP	Procollagen type I N propeptide
CVD	Cardiovascular disease	PTH	Parathyroid hormone
DCOR	Dialysis in Clinical Outcomes Revisited	PWV	Pulse wave velocity
DOPPS	Dialysis Outcomes and Practice Pattern Study	qCT	Quantitative computed tomography
DPD	Deoxypyridinoline	QOL	Quality of life
DXA	Dual energy X-ray absorptiometry	qUS	Quantitative ultrasonography
EBCT	Electron beam computed tomography	RANK-L	Receptor Activator for Nuclear Factor kB Ligand
eGFR	Estimated glomerular filtration rate	RCT	Randomized controlled trial
ELISA	Enzyme-linked immunosorbent assay	rhGH	Recombinant human growth hormone
ERT	Evidence review team	RIA	Radioimmunoassay
FDA	Food and Drug Administration	RIND	Renagel in New Dialysis
FGF	Fibroblast growth factor	RR	Relative risk
GFR	Glomerular filtration rate	s.d.	Standard deviation
HD	Hemodialysis	SDS	Standard deviation score
HDL-C	High-density lipoprotein cholesterol	SEEK	Study to Evaluate Early Kidney Disease
HPLC	High-performance liquid chromatography	SERM	Selective estrogen receptor modulator
HPT	Hyperparathyroidism	SF-36	Medical Outcomes Study Short Form 36
HR	Hazard ratio	t-ALP	Total alkaline phosphatases
IMT	Intimal-medial thickness	TMV	Turnover, mineralization, volume
IP	Intraperitoneal	TRAP	Tartrate-resistant acid phosphatase
iPTH	Intact parathyroid hormone	TV	Tissue volume
IRMA	Immunoradiometric assay	US	Ultrasonography
IU	International Unit	VDR	Vitamin D receptor
IV	Intravenous	WHO	World Health Organization
KDIGO	Kidney Disease: Improving Global Outcomes

Mission Statement:

Abbreviations and acronyms